Carcinoid Syndrome Efficacy Study Featuring an Oral Daily Paltusotine Regimen

ClinicalTrials.gov ID: NCT07087054

Public ClinicalTrials.gov record NCT07087054. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced May 4, 2026, 1:39 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Parallel Group, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Paltusotine in Adults With Carcinoid Syndrome Due to Well-Differentiated Neuroendocrine Tumors

Study identification

NCT ID: NCT07087054
Recruitment status: Recruiting
Study type: Interventional
Phase: Phase 3
Lead sponsor: Crinetics Pharmaceuticals Inc.; Industry
Enrollment: 141 participants

Conditions and interventions

Conditions

Interventions

Paltusotine Drug
Placebo Drug

Drug

Eligibility (public fields only)

Age range: 18 Years and older
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Nov 18, 2025
Primary completion: Jul 31, 2027
Completion: Dec 31, 2029
Last update posted: Apr 29, 2026

2025 – 2030

United States locations

U.S. sites: 17
U.S. states: 16
U.S. cities: 17

Facility	City	State	ZIP	Site status
Banner MD Anderson Cancer Center	Gilbert	Arizona	85234	Recruiting
Hoag Memorial Hospital Presbyterian	Newport Beach	California	92663	Recruiting
Yale University - New Haven Hospital - Yale Cancer Center	New Haven	Connecticut	06510	Recruiting
University of Miami	Miami	Florida	33136	Recruiting
Moffitt Cancer Center	Tampa	Florida	33612	Recruiting
Winshop Cancer Institute - Emory University	Atlanta	Georgia	30322	Recruiting
University of Iowa Health Care	Iowa City	Iowa	52242	Recruiting
University of Kentucky Medical Center	Lexington	Kentucky	40536	Recruiting
Louisiana State University Health Sciences	Metairie	Louisiana	70006	Recruiting
Henry Ford Cancer - Detroit	Detroit	Michigan	48202	Recruiting
Mayo Clinic	Rochester	Minnesota	55905	Recruiting
Icahn School of Medicine at Mount Sinai	New York	New York	10029	Recruiting
University Hospitals Cleveland Medical Center	Cleveland	Ohio	44106	Recruiting
Hospital of the University of Pennsylvania	Philadelphia	Pennsylvania	19104	Recruiting
Huntsman Cancer Institute, University of Utah	Salt Lake City	Utah	84112	Recruiting
University of Virginia Comprehensive Cancer Center	Charlottesville	Virginia	22903	Recruiting
Medical College of Wisconcin	Milwaukee	Wisconsin	53222	Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 34 non-U.S. sites.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT07087054, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Apr 29, 2026 · Synced May 4, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT07087054 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →